Dual Antiplatelet Therapy

Alternative Names: DAPT

Dual antiplatelet therapy (usually aspirin plus clopidogrel) is used after a minor ischemic stroke or high-risk TIA to reduce the risk of early recurrence. It is most effective when started promptly and continued for 21–90 days, after which patients transition back to single antiplatelet therapy. Studies have shown that short-term DAPT provides better protection against recurrent stroke than aspirin alone. However, prolonged use increases bleeding risk, so therapy duration is limited. DAPT is now a well-established part of secondary prevention protocols in carefully selected patients.

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: N/A

Review Summary

0

0 Reviews

Preferred by 0 Reviewers

Based on the review by Dr. Curbside, Dual Antiplatelet Therapy (DAPT) appears to be an effective treatment for reducing early recurrence risk in minor ischemic stroke or high-risk transient ischemic attack (TIA). However, the treatment requires careful management due to the balance between potential benefits and bleeding risks, and is typically recommended for a short-term course under neurology guidance.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
0
1 = Very Expensive 5 = Very Affordable

0

Very Expensive
Relief Speed
0
1 = No Relief 5 = Immediate Relief

0

No Relief
Side Effects
0
1 = Intolerable Effect 5 = No Effect

0

Intolerable Effect
Treatment Line
0
1 = Third-line or more 5 = First-line

0

Third-line or more

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

5
0%
4
0%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review by Dr. Curbside, Dual Antiplatelet Therapy (DAPT) appears to be an effective treatment for reducing early recurrence risk in minor ischemic stroke or high-risk transient ischemic attack (TIA). However, the treatment requires careful management due to the balance between potential benefits and bleeding risks, and is typically recommended for a short-term course under neurology guidance.

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried

No reviews yet.

Be the first to share your experience with this treatment. Your insights help others make informed decisions about their care.